RTA-403 analog (Reata)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameRTA-403 analog (Reata)
Drug Alias Nameanti-inflammatory tricyclic bis-enones (Dartmouth College/University of Texas)anti-inflammatory tricyclic bis-enones (Reata)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeme oxygenase modulators
TargetsHeme oxygenase
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDartmouth College
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDartmouth CollegeReata Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A